Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-25-004348

Options or other derivatives

  • Chief Executive Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Vitoc Vlad Chief Executive Officer 2025-02-10 Grant or award · Stock Options +400,000 400,000 D
Loading xslF345X05/form4.xml…